NASDAQ:PHIO | Insider Transactions — Page 2 | Phio Pharmaceuticals Corp.

PHIO Insider Transactions — Page 2

149 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–149; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
CAUWENBERGH GEERTPresident & CEO2013-10-03Purchase100.0$3.51
CAUWENBERGH GEERTPresident & CEO2013-09-30Purchase300.0$3.42
CAUWENBERGH GEERTPresident & CEO2013-09-26Purchase300.0$3.5
CAUWENBERGH GEERTPresident & CEO2013-09-24Purchase100.0$3.49
CAUWENBERGH GEERTPresident & CEO2013-09-23Purchase174.0$3.49
CAUWENBERGH GEERTPresident & CEO2013-09-20Purchase326.0$3.52
CAUWENBERGH GEERTPresident & CEO2013-09-18Purchase100.0$3.48
CAUWENBERGH GEERTPresident & CEO2013-09-18Purchase100.0$3.5
CAUWENBERGH GEERTPresident & CEO2013-09-17Purchase200.0$3.55
CAUWENBERGH GEERTPresident & CEO2013-09-13Purchase100.0$3.6
CAUWENBERGH GEERTPresident & CEO2013-09-13Purchase100.0$3.55
CAUWENBERGH GEERTPresident & CEO2013-09-11Purchase150.0$3.55
CAUWENBERGH GEERTPresident & CEO2013-09-10Purchase150.0$3.58
CAUWENBERGH GEERTPresident & CEO2013-09-10Purchase200.0$3.65
CAUWENBERGH GEERTPresident & CEO2013-08-30Purchase200.0$3.35
CAUWENBERGH GEERTPresident & CEO2013-08-30Purchase100.0$3.38
CAUWENBERGH GEERTPresident & CEO2013-08-29Purchase200.0$3.55
CAUWENBERGH GEERTPresident & CEO2013-08-29Purchase200.0$3.4
Lockshin CurtisDirector2013-08-29Purchase1,000.0$3.7
CAUWENBERGH GEERTPresident & CEO2013-08-28Purchase100.0$3.7
CAUWENBERGH GEERTPresident & CEO2013-08-28Purchase100.0$3.6
CAUWENBERGH GEERTPresident & CEO2013-08-28Purchase200.0$3.75
CAUWENBERGH GEERTPresident & CEO2013-08-27Purchase100.0$3.7
Bitterman Robert JDirector2013-08-26Purchase500.0$3.9
CAUWENBERGH GEERTPresident & CEO2013-08-23Purchase200.0$3.69
CAUWENBERGH GEERTPresident & CEO2013-08-23Purchase100.0$3.75
CAUWENBERGH GEERTPresident & CEO2013-08-22Purchase300.0$3.62
CAUWENBERGH GEERTPresident & CEO2013-08-21Purchase680.0$3.8
CAUWENBERGH GEERTPresident & CEO2013-08-20Purchase200.0$3.75
CAUWENBERGH GEERTPresident & CEO2013-08-20Purchase200.0$3.7
CAUWENBERGH GEERTPresident & CEO2013-08-20Purchase300.0$3.9
CAUWENBERGH GEERTPresident & CEO2013-08-19Purchase100.0$3.65
CAUWENBERGH GEERTPresident & CEO2013-08-19Purchase120.0$3.67
CAUWENBERGH GEERTPresident & CEO2013-08-19Purchase100.0$3.86
CAUWENBERGH GEERTPresident & CEO2013-08-06Purchase350.0$4.05
CAUWENBERGH GEERTPresident & CEO2013-08-05Purchase150.0$4.03
CAUWENBERGH GEERTPresident & CEO2013-08-05Purchase500.0$4.0
Bitterman Robert JDirector2013-08-05Purchase100.0$4.05
Bitterman Robert JDirector2013-08-05Purchase100.0$4.02
Bitterman Robert JDirector2013-08-05Purchase100.0$4.01
Bitterman Robert JDirector2013-08-05Purchase200.0$4.05
Bitterman Robert JDirector2013-08-05Purchase500.0$4.13
CAUWENBERGH GEERTPresident & CEO2013-07-31Purchase167.0$4.02
CAUWENBERGH GEERTPresident & CEO2013-07-31Purchase500.0$4.1
CAUWENBERGH GEERTPresident & CEO2013-07-29Purchase500.0$4.54
CAUWENBERGH GEERTPresident & CEO2013-07-26Purchase500.0$4.87
Galena Biopharma, Inc.TenPercentOwner2013-05-02Sale253,000.0$0.19
Galena Biopharma, Inc.TenPercentOwner2013-05-01Sale659,500.0$0.19
Galena Biopharma, Inc.TenPercentOwner2013-04-30Sale171,000.0$0.21